Creation of a Clinical Database for the Study of Phenotypic Variability in Motor Neuron Diseases

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIstituto Auxologico Italiano

About this trial

Study Description: Characterization of Motor Neuron Disease Phenotypes

The goal of this observational study is to understand the clinical presentation of motor neuron disease (MND) in patients attending the Neurology Department of the Istituto Auxologico Italiano. The main questions it aims to answer are:

* What are the specific clinical phenotypes associated with MND? * How can these phenotypes contribute to a better understanding of the disease's underlying mechanisms and improve prognostic accuracy?

Participants will undergo:

* Clinical evaluation using validated scales * Neurophysiological and neuroradiological instrumental assessment * Neuropsychological evaluation * Collection of biological materials for genetic screening and biomarker assessment, if necessary.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

diagnosis of ALS or other motor neuron disease

Disqualifiers

refusal to participate to the study

Trial population

Consecutive cohort of patients from a tertiary Italian ALS Centre

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

no. of patients with classic ALS

no. of patients with classic ALS

Time frame
baseline (at diagnosis), at 1 year
2

no. of patients with bulbar ALS

no. of patients with bulbar ALS

Time frame
baseline (at diagnosis), at 1 year
3

no. of patients with LMN phenotypes (flail arm, flail leg, PMA)

no. of patients with LMN phenotypes (flail arm, flail leg, PMA)

Time frame
baseline (at diagnosis), at 1 year
4

no. of patients with UMN phenotypes (pyramidal ALS, PLS)

no. of patients with UMN phenotypes (pyramidal ALS, PLS)

Time frame
baseline (at diagnosis), at 1 year

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.